Evaluation of Pre-Sarcopenia and Sarcopenia in a Well-Nourished Late-Middle-Aged Population: A Feasibility Study of a Registry

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 202

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JNFH-10-4_004

تاریخ نمایه سازی: 26 دی 1401

چکیده مقاله:

Introduction : Sarcopenia is characterized by weakness of the skeletal muscles. This study aimed to evaluate the prevalence of sarcopenia and its relationship with dietary intake, socioeconomic status, depression, lifestyle, and physical activity for the first time in a well-nourished over ۵۵ year’s old population. Methods: This study was conducted on a well-nourished above ۵۵ years old population. The European Working Group on Sarcopenia in Older People-۲ (EWGSOP-۲) guideline was used to determine the prevalence of sarcopenia. Muscle mass was assessed using bioelectrical impedance analysis. Muscle strength and performance were evaluated using handgrip and gait speed, respectively. The dietary intake, socioeconomic status, psychological health, lifestyle, clinical factors, and physical activity were examined using valid tools. Results: A total of ۷۶۶ well-nourished individuals (mean age=۶۵.۱۴±۶.۸۴ years old; male:female ratio= ۱:۱.۹۹) were evaluated for sarcopenia. The prevalence of pre-, confirmed-, and severe sarcopenia were ۲۳.۹%, ۱.۸%, and ۱.۳%, respectively. Age was significantly related to sarcopenia (OR=۱.۰۹۶ (۹۵% CI: ۱.۰۶۹-۱.۱۲۴), p<۰.۰۰۱). Females had an increased risk of pre-sarcopenia (OR=۲.۱۸۹ [۹۵% CI: ۱.۴۸-۳.۲۳۹], p=۰.۰۰۲), while males were at higher risk of confirmed and severe sarcopenia (OR=۱۵.۱۰۲ [۹۵% CI: ۴.۴۶۱-۵۱.۱۳۱], p<۰.۰۰۱). The decision tree model of sarcopenia indicated age as the main predictor for sarcopenia. Conclusion: According to EWGSOP-۲, the overall prevalence of sarcopenia was ۲۷% among well-nourished almost healthy elderly population. There was a relationship between age and sarcopenia. Females and males were at higher risk of pre-sarcopenia and confirmed and severe sarcopenia; respectively. Further research is strongly suggested to asses pre-sarcopenia.

کلیدواژه ها:

نویسندگان

Mohammed Reza Shadmand Foumani Moghadam

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Sharif Etemadi

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Federico Bozzetti

Faculty of Medicine, University of Milan, Milan, Italy.

Mohammad Amushahi

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Reyhane Bakhshipour

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Parnian Pezeshki

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Majid Ghayour-Mobarhan

Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Majid Khadem-rezaiyan

Department of Community Medicine and Public Health, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Khashayar Khanizade

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

Luciana B Sutanto

Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia.

Gordon Ferns

Division of Medical Education, Brighton, and Sussex Medical School, Falmer, Brighton, BN۱ ۹PH, Sussex, UK.

Zohreh Hosseini

Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. The Lancet. ۲۰۱۹ ...
  • Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, ...
  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, ...
  • Zhuang C-L, Shen X, Zou H-B, Dong Q-T, Cai H-Y, ...
  • Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster J-Y. ...
  • Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, ...
  • Petermann‐Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, ...
  • Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, ...
  • Sanchez-Rodriguez D, Bruyère O. The International Registry of patients with ...
  • Shadmand Foumani Moghadam MR, Dahakzade F, Shariatmadar Tehrani N, Molavi ...
  • Rubenstein LZ, Harker JO, Salvà A, Guigoz Y, Vellas B. ...
  • Gupta N, Balasekaran G, Govindaswamy VV, Hwa CY, Shun LM. ...
  • Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing sarcopenia ...
  • Di Vincenzo O, Marra M, Di Gregorio A, Pasanisi F, ...
  • Maughan R. An evaluation of a bioelectrical impedance analyser for ...
  • Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, ...
  • Schaap LA, Quirke T, Wijnhoven HA, Visser M. Changes in ...
  • Hashimoto Y, Kaji A, Sakai R, Hamaguchi M, Okada H, ...
  • Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, ...
  • Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short ...
  • Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, ...
  • Dadfar M, Kalibatseva Z. Psychometric properties of the persian version ...
  • Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety ...
  • Sharifi SF, Javadi M, Barikani A. Reliability and validity of ...
  • Ayoubi SS, Nematy M, Amini M, Esmaily H, Movahed S, ...
  • Knüppel S, Norman K, Boeing H. Is a Single ۲۴-hour ...
  • Luo H, Dodd KW, Arnold CD, Engle-Stone R. A New ...
  • Coll PP, Phu S, Hajjar SH, Kirk B, Duque G, ...
  • Shafiee G, Heshmat R, Ostovar A, Khatami F, Fahimfar N, ...
  • Fahimfar N, Gharibzadeh S, Khashayar P, Rajabian R, Omrani GR, ...
  • Hashemi R, Shafiee G, Motlagh AD, Pasalar P, Esmailzadeh A, ...
  • Sousa-Santos AR, Afonso C, Borges N, Santos A, Padrão P, ...
  • Su Y, Hirayama K, Han T-f, Izutsu M, Yuki M. ...
  • Purcell S, MacKenzie M, Barbosa-Silva T, Dionne I, Ghosh S, ...
  • Pelegrini A, Mazo GZ, Pinto AdA, Benedetti TRB, Silva DAS, ...
  • Sui SX, Holloway‐Kew KL, Hyde NK, Williams LJ, Tembo MC, ...
  • Pang BWJ, Wee S-L, Lau LK, Jabbar KA, Seah WT, ...
  • Liu X, Hou L, Xia X, Liu Y, Zuo Z, ...
  • Martone AM, Marzetti E, Salini S, Zazzara MB, Santoro L, ...
  • Yoo S, Kim D-Y, Lim H. Sarcopenia in relation to ...
  • Savas S, Taşkıran E, Sarac FZ, Akcicek F. A cross-sectional ...
  • Benjumea A-M, Curcio C-L, Duque G, Gomez F. Dynapenia and ...
  • Bae E-J, Kim Y-H. Factors affecting sarcopenia in Korean adults ...
  • Menant J, Weber F, Lo J, Sturnieks D, Close J, ...
  • Santoro A, Bazzocchi A, Guidarelli G, Ostan R, Giampieri E, ...
  • Agha-Alinejad H, Gharakhanlou R, Farzad B, Bayati M. Norms of ...
  • Linge J, Heymsfield SB, Dahlqvist Leinhard O. On the definition ...
  • Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, ...
  • Wang P-y, Li Y, Wang Q. Sarcopenia: An underlying treatment ...
  • نمایش کامل مراجع